Shin Park - OliX PharmaceuticalsI Sr Devel

All Insiders . Korea . 
Stock . OliX PharmaceuticalsInc . Stakeholders . Insider . Shin Park
226950 Stock   21,100  1,000.00  4.98%   

Insider

Shin Park is Sr Devel of OliX PharmaceuticalsInc
Phone82 3 1779 8400
Webhttp://www.olixpharma.com

Shin Park Latest Insider Activity

Tracking and analyzing the buying and selling activities of Shin Park against OliX PharmaceuticalsI stock is an integral part of due diligence when investing in OliX PharmaceuticalsI. Shin Park insider activity provides valuable insight into whether OliX PharmaceuticalsI is net buyers or sellers over its current business cycle. Note, OliX PharmaceuticalsI insiders must abide by specific rules, including filing SEC forms every time they buy or sell OliX PharmaceuticalsI'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
 
Shin Park over six months ago
Acquisition by Shin Park of 9000 shares of MagnaChip Semiconductor at 5.56 subject to Rule 16b-3
 
Shin Park over a year ago
Payment of 1391 shares by Shin Park of MagnaChip Semiconductor subject to Rule 16b-3
 
Shin Park over a year ago
Acquisition by Shin Park of 37523 shares of MagnaChip Semiconductor subject to Rule 16b-3

OliX PharmaceuticalsI Management Efficiency

The company has return on total asset (ROA) of (0.164) % which means that it has lost $0.164 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (76.6277) %, meaning that it generated substantial loss on money invested by shareholders. OliX PharmaceuticalsI's management efficiency ratios could be used to measure how well OliX PharmaceuticalsI manages its routine affairs as well as how well it operates its assets and liabilities.
OliX PharmaceuticalsInc has accumulated 20.38 B in total debt. Debt can assist OliX PharmaceuticalsI until it has trouble settling it off, either with new capital or with free cash flow. So, OliX PharmaceuticalsI's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OliX PharmaceuticalsInc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OliX to invest in growth at high rates of return. When we think about OliX PharmaceuticalsI's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

SangHo ParkISU Abxis Co
61
Jong WonABL Bio
N/A
YoungSoo SohnISU Abxis Co
70
Jong KimABL Bio
N/A
Jung KimABL Bio
N/A
SeongJin KimMedPacto
N/A
HeungRok ParkISU Abxis Co
60
Jaecheon LeeABL Bio
N/A
SungHo ChoiISU Abxis Co
N/A
HyunIl KimISU Abxis Co
N/A
Seungho KimISU Abxis Co
57
Jae JungABL Bio
N/A
Ilho HaMedPacto
N/A
Park WuGreen Cross Lab
N/A
ChangHoon ChoiISU Abxis Co
63
You WeonKyooABL Bio
N/A
YuKyeong HwangGreen Cross Lab
56
JaeHeung LeeISU Abxis Co
N/A
Heungsik YoonOLIPASS
N/A
JoonYoung ParkISU Abxis Co
N/A
JinChul ShinISU Abxis Co
56
OliX PharmaceuticalsInc (226950) is traded on KOSDAQ in Korea and employs 67 people.

Management Performance

Return On Equity-76.63
Return On Asset-0.16

OliX PharmaceuticalsInc Management Team

Elected by the shareholders, the OliX PharmaceuticalsI's board of directors comprises two types of representatives: OliX PharmaceuticalsI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OliX. The board's role is to monitor OliX PharmaceuticalsI's management team and ensure that shareholders' interests are well served. OliX PharmaceuticalsI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OliX PharmaceuticalsI's outside directors are responsible for providing unbiased perspectives on the board's policies.
SunWoo Hong, VP Director
Shin Park, Sr Devel
DongKi Lee, CEO Director

OliX Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OliX PharmaceuticalsI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-76.63
Return On Asset-0.16
Operating Margin(6.56) %
Current Valuation576.53 B
Shares Outstanding6.51 M
Shares Owned By Insiders29.21 %
Shares Owned By Institutions6.02 %
Price To Sales75.58 X
Revenue3.67 B
Gross Profit2.42 B

Pair Trading with OliX PharmaceuticalsI

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OliX PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OliX PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.

Moving together with OliX Stock

  0.66326030 Sk BiopharmaceuticalsPairCorr
  0.73298380 ABL BioPairCorr

Moving against OliX Stock

  0.49012700 LEADCORPPairCorr
  0.43101400 N CitronPairCorr
  0.39235980 MedPactoPairCorr
  0.37012860 Mobase Electronics CoLtdPairCorr
  0.36122690 Seojin Automotive CoLtdPairCorr
The ability to find closely correlated positions to OliX PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OliX PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OliX PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OliX PharmaceuticalsInc to buy it.
The correlation of OliX PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OliX PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OliX PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OliX PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in OliX Stock

OliX PharmaceuticalsI financial ratios help investors to determine whether OliX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OliX with respect to the benefits of owning OliX PharmaceuticalsI security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY